# Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.

> **NCT05069259** · — · TERMINATED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **OTHER:** Stool sample collection

## Key facts

- **NCT ID:** NCT05069259
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-28
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Study was terminated due to difficulty in enrolling targeted number of participants. There were no safety and/or efficacy concerns in the decision to stop enrollment.
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069259, "Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05069259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*